Welcome to the 26th WONCA Europe Virtual Conference Programme Scheduling

The conference will officially run on Central European Summer Time (CEST). To convert the conference times to your local time Click Here

The viewing of sessions and E-Posters cannot be accessed from this conference calendar. All sessions and E-Posters are accessible via the Main Lobby in the virtual platform. 

Icons Legend:  - Fully Live Session  - On Demand with Live Q&A  - Pre-Registration Required
 

            

Displaying One Session

Hall 5

ORAL PRESENTATIONS
Session Type
ORAL PRESENTATIONS
Date
07.07.2021, Wednesday
Session Time
05:30 PM - 07:00 PM
Room
Hall 5
Session Icon
Pre-Recorded with Live Q&A

TELEMATIC MONITORING OF COVID 19 PATIENTS DURING THE PANDEMIC IN A PRIMARY CARE CENTER

Date
07.07.2021, Wednesday
Session Time
05:30 PM - 07:00 PM
Room
Hall 5
Lecture Time
05:30 PM - 05:41 PM
Session Icon
Pre-Recorded with Live Q&A

Abstract

Abstract Body

Background and purpose: COVID-19 pandemic has had a great impact and has changed the way of working, especially in primary care, where telephone assistance has been used in the management of mild-moderate patients who did not require admission. The objective of our study was to know the usefulness of the telephone assistance during the covid-19 pandemic period.

Methods: Descriptive study of patients monitored by telephone for COVID-19 at the CAP of Canet de Mar from 03/16/20 to 05/29/20. An anonymous Excel database was created, collecting data of sociodemographic characteristics, COVID symptoms, COVID tests results, and clinical evolution. For the data analysis, the R student program was used. For the descriptive analysis of the qualitative variables, the frequency and the percentage are shown, for the quantitative variables the mean and standard deviation are shown if the variable has a normal distribution or the median and the interquartile range otherwise.

Results: We included 416 patients, 1141 phone calls made, women (56%), mean age 45.31 (interquartile range between 36 and 56). Men had a higher average age. Diagnosis more observed was “Covid case”(31%) and “Covid contact”(31%). Most of avaluation was telematic, only 1% hospitalizated and exitus was 1%. Hospitalization was greater in men and in advanced age. Mortality was higher in women.

Conclusions: Telephone assistance during the pandemic is useful for the control of mild to moderate patients.

Hide

ENGAGING MIGRANTS WITH INFECTIOUS DISEASE SCREENING AND CATCH-UP VACCINATION IN PRIMARY CARE: INNOVATIONS AND NOVEL APPROACHES.

Date
07.07.2021, Wednesday
Session Time
05:30 PM - 07:00 PM
Room
Hall 5
Lecture Time
05:41 PM - 05:52 PM
Session Icon
Pre-Recorded with Live Q&A

Abstract

Abstract Body

Background

Migration in Europe has risen substantially. Data shows that migrants face disproportionate burden of infections (tuberculosis, HIV, hepatitis, parasitic-infection) which go undiagnosed with potentially fatal complications. This population are also under-immunised, with migrants involved in outbreaks of vaccine-preventable-diseases.

There are major shortfalls in migrant infectious disease screening and catch-up vaccination. The ECDC recently called for innovative implementation strategies within primary-care.

This interactive session draws together research and innovation from across primary-care in Europe, to provide opportunities for discussion and sharing of challenges and solutions.

Aims:

Deepen understanding of infectious disease burden faced by migrants and understand scale of underdiagnosis and under-vaccination identified in recent European research.

Review successes and challenges of policies adopted by European countries.

Share examples of best practice/innovation

Critique 2 novel primary-care approaches from Spain and UK.

Reflect on how workshop will change practice

Timetable:

1 X 20 min-minute presentation drawing together recent research on infectious disease burden and under-vaccination of migrants in Europe and summarising current European policies successes and failures. (20 mins)

Interactive critique exercise of 2 novel screening and vaccination interventions (40mins)

Small-group discussion of barriers and facilitators to screening and catch-up vaccination in primary-care context with attendees to give examples of local innovation. (20 mins)

Whole-group summary of session with take-home solutions. (10 mins)

Conclusion:

This workshop aims to present evidence of high burden of infectious disease faced by migrants, to share examples of international innovation/best practice, provide a platform to discuss practical solutions and barriers to implementation of infectious disease screening and catch-up vaccination within primary-care settings and generate take home solutions

Hide

GENETIC RISK ASSESSMENT BASED ON A THREE-GENERATION FAMILY HISTORY: PRELIMINARY RESULTS FROM SLOVENIA

Date
07.07.2021, Wednesday
Session Time
05:30 PM - 07:00 PM
Room
Hall 5
Lecture Time
05:52 PM - 06:03 PM
Session Icon
Pre-Recorded with Live Q&A

Abstract

Abstract Body

Background and purpose

Well-validated tools for collecting family history can enable risk assessment for specific disease groups.

The purpose of this study was to determine high genetic risk for monogenetic and multifactorial diseases with an important genetic component in a population of people without medically proven chronic diseases, solely by an algorithm developed for this purpose.

Methods

A cross-sectional study in 40 Slovenian purposively sampled family medicine practices (FMPs) was carried-out in 2019. The participants came to FMPs for a preventive examination (30 for each FMP) and completed a questionnaire covering the basic demographic data. An algorithm using a Three-generation family history on monogenetic and complex genetic diseases was developed for genetic risk assessment, risk was categorised as average, moderate or high.

Results

There were 1,041 participants in this study, aged 42.7 ± 8.4 years; of all, 366 (35.2%) were males.

High genetic risk for any of studied disease was detected in 183 (17.6%) participants. High genetic risk for cancer, familiar hypercholesterolemia, and/or cardiovascular disease were assessed most often. However, these patients were previously not detected through common clinical management.

Conclusions

Our study offered prevalence data on genetic risk based on Three-generational family history for most of the diseases with a genetic component. The tool, which was developed in this study, showed potential for a great clinical usefulness; further validations will prove its efficiency and contribution in a patient-centered healthcare.

Hide

TRAVEL FROM HOME? VIRTUAL EXCHANGES - ARE VIRTUAL EXCHANGES THE FUTURE OF INTERNATIONAL GENERAL PRACTICE EXPOSURE?

Date
07.07.2021, Wednesday
Session Time
05:30 PM - 07:00 PM
Room
Hall 5
Lecture Time
06:03 PM - 06:14 PM
Session Icon
Pre-Recorded with Live Q&A

Abstract

Abstract Body

Background

International GP exchanges are a highly valued way to share and experience different knowledge, skills and values. They are a mutually enriching method of learning from global health experience. Life commitments, cost, and current restrictions mean that physical travel to another country may not always be possible or convenient. This risks lost opportunities for learning, networking and personal development.

Aim

We aim to provide an evidence based overview of virtual practice exchanges, exploring what this might look like in different national contexts.

Methods/timetable

The session will consist of:

A brief interactive introduction to practice exchanges (5 min)

Presentation of the findings from a structured scoping review on virtual clinical exchanges (10 min)

Participants will then be able to take part in an abbreviated virtual exchange to a GP practice within the UK (15 min)

This will be followed by Q+A with UK GPs (10 min)

Case studies and lessons learned from virtual VdGM practice exchanges including the WONCA Berlin and Waynakay preconferences will be presented (10 min)

Participants will split into breakout groups to discuss what a virtual practice exchange might look like in their national context (20 min)

The session will close with open questions, answers and discussion to hosts and participants of previous virtual practice exchanges (15 min)

Conclusions

Participants will have an understanding of the definition and theory of a virtual practice exchange. This will be complemented by experiencing an exchange, hearing the practicalities of exchange organisation, and considering how a virtual exchange might work in their national context.

Hide

DEFENSIVE MEDICINE AND ITS PERCEPTION IN PRIMARY HEALTHCARE

Date
07.07.2021, Wednesday
Session Time
05:30 PM - 07:00 PM
Room
Hall 5
Lecture Time
06:14 PM - 06:25 PM
Session Icon
Pre-Recorded with Live Q&A

Abstract

Abstract Body

Defensive Medicine and its perception in Primary Healthcare

Background and purpose

Defensive medicine (DM) is defined as a deviation from standard medical practice for fear of medical malpractice claims and has serious consequences for patients, doctors and public funds. Our aim is to understand the perception of the practice of DM in Primary Health Care, specifically in the Health Centers Group of West Lisbon and Oeiras (HCG WLO).

Methods

We conducted a cross-sectional study between May 2019 and September 2020, including all 182 physicians working at HCG WLO. Each participant received a questionnaire to answer within two months and the results were analysed through SPSS® version 27.

Results

We included 138 questionnaires (11 excluded and 33 not answered). 61% of physicians consider DM a moderate problem and 92.2% have already practiced DM, which includes ordering additional exams (93,7%), referring more to secondary care (53,2%) and scheduling further appointments (34,9%). The main reasons for DM are the need for more information to make safer decisions (63,8%) and patient insistence on performing extra procedures (55,9%). 68.3% believe that practicing DM reduces malpractice claims.

Conclusions

Most physicians practice DM, although they consider it a problem and recognise its elevated costs. They believe that protocol development, legal support improvement, consultation time adjustment and health literacy promotion may diminish the problem. It was not possible to establish a statistical association between workplace, medical category, and DM practice due to the low number of participants. The research team aims to apply this protocol nationwide for more valid results and to promote new policies.

Hide

ENVIRONMENTAL IMPACT OF PHARMACEUTICALS IN GUIDELINES

Date
07.07.2021, Wednesday
Session Time
05:30 PM - 07:00 PM
Room
Hall 5
Lecture Time
06:25 PM - 06:36 PM
Session Icon
Pre-Recorded with Live Q&A

Abstract

Abstract Body

Introduction

In general practice, the greatest CO2 emission (49%) is caused by pharmaceuticals. Also, pharmaceutical residues in effluents can lead to ecotoxicity. Adding sustainability as an extra criterium to achieve advices of good quality in guidelines is therefore urgently needed. Many doctors are motivated to work more sustainable, but are hindered by lack of knowledge. Our goal was to give information on environmental impact of pharmaceuticals in two Dutch guidelines: ‘Asthma in adults’ and ‘Anaemia’.

Methods

During the development of both guidelines, we collected published data on environmental impact of pharmaceuticals, information on pharmaceutical ingredients and additives from the Summary of Product Characteristics (SMPC) of each registered drug and used information on environmental impact from the Swedish website www.fass.se. We consulted an expert on environmental impact of greenhouse gases used in MDI’s for the treatment of asthma. For the impact of residues of iron supplements on water we consulted a toxicologist and pharmacist.

Results

Sustainability was used as one of the criteria for therapeutical advice in both updated guidelines. We added information on the negative impact of MDI’s when choosing an inhaler for the treatment of asthma. We preferred ferrous fumarate tablets for the treatment of iron deficiency and advised against the use of ferrous sulfate slow release tablets that are not fully biodegradable.

Conclusion

Implementing environmental impact of pharmaceuticals in guidelines through a multidisciplinary approach, can be an effective way of increasing knowledge on sustainability of pharmaceuticals and can give doctors tools to prescribe more environmentally friendly.

Hide

LIVE Q&A

Date
07.07.2021, Wednesday
Session Time
05:30 PM - 07:00 PM
Room
Hall 5
Lecture Time
06:36 PM - 06:56 PM
Session Icon
Pre-Recorded with Live Q&A